Table of Contents

1 Report Overview

• 1.1 Research Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Bisacodyl Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Low Purity
  • 1.3.3 High Purity
• 1.4 Market Segment by Application
  • 1.4.1 Global Bisacodyl Market Share by Application (2019-2025)
  • 1.4.2 Constipation
  • 1.4.3 Neurogenic Bowel Dysfunction
  • 1.4.4 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Production and Capacity Analysis
  • 2.1.1 Global Bisacodyl Production Value 2014-2025
  • 2.1.2 Global Bisacodyl Production 2014-2025
  • 2.1.3 Global Bisacodyl Capacity 2014-2025
  • 2.1.4 Global Bisacodyl Marketing Pricing and Trends
• 2.2 Key Producers Growth Rate (CAGR) 2019-2025
  • 2.2.1 Global Bisacodyl Market Size CAGR of Key Regions
  • 2.2.2 Global Bisacodyl Market Share of Key Regions
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Capacity and Production by Manufacturers
  • 3.1.1 Global Bisacodyl Capacity by Manufacturers
  • 3.1.2 Global Bisacodyl Production by Manufacturers
• 3.2 Revenue by Manufacturers
  • 3.2.1 Bisacodyl Revenue by Manufacturers (2014-2019)
  • 3.2.2 Bisacodyl Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Bisacodyl Market Concentration Ratio (CR5 and HHI)
• 3.3 Bisacodyl Price by Manufacturers
• 3.4 Key Manufacturers Bisacodyl Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Bisacodyl Market
• 3.6 Key Manufacturers Bisacodyl Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Production and Production Value for Each Type
  • 4.1.1 Low Purity Production and Production Value (2014-2019)
  • 4.1.2 High Purity Production and Production Value (2014-2019)
• 4.2 Global Bisacodyl Production Market Share by Type
• 4.3 Global Bisacodyl Production Value Market Share by Type
• 4.4 Bisacodyl Ex-factory Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Bisacodyl Consumption by Application

6 Production by Regions

• 6.1 Global Bisacodyl Production (History Data) by Regions 2014-2019
• 6.2 Global Bisacodyl Production Value (History Data) by Regions
• 6.3 United States
  • 6.3.1 United States Bisacodyl Production Growth Rate 2014-2019
  • 6.3.2 United States Bisacodyl Production Value Growth Rate 2014-2019
  • 6.3.3 Key Players in United States
  • 6.3.4 United States Bisacodyl Import & Export
• 6.4 European Union
  • 6.4.1 European Union Bisacodyl Production Growth Rate 2014-2019
  • 6.4.2 European Union Bisacodyl Production Value Growth Rate 2014-2019
  • 6.4.3 Key Players in European Union
  • 6.4.4 European Union Bisacodyl Import & Export
• 6.5 China
  • 6.5.1 China Bisacodyl Production Growth Rate 2014-2019
  • 6.5.2 China Bisacodyl Production Value Growth Rate 2014-2019
  • 6.5.3 Key Players in China
  • 6.5.4 China Bisacodyl Import & Export
• 6.6 Rest of World
  • 6.6.1 Japan
  • 6.6.2 Korea
  • 6.6.3 India
  • 6.6.4 Southeast Asia

7 Bisacodyl Consumption by Regions

• 7.1 Global Bisacodyl Consumption (History Data) by Regions
• 7.2 United States
  • 7.2.1 United States Bisacodyl Consumption by Type
  • 7.2.2 United States Bisacodyl Consumption by Application
• 7.3 European Union
  • 7.3.1 European Union Bisacodyl Consumption by Type
  • 7.3.2 European Union Bisacodyl Consumption by Application
• 7.4 China
  • 7.4.1 China Bisacodyl Consumption by Type
  • 7.4.2 China Bisacodyl Consumption by Application
• 7.5 Rest of World
  • 7.5.1 Rest of World Bisacodyl Consumption by Type
  • 7.5.2 Rest of World Bisacodyl Consumption by Application
  • 7.5.1 Japan
  • 7.5.2 Korea
  • 7.5.3 India
  • 7.5.4 Southeast Asia

8 Company Profiles

• 8.1 Cambrex
  • 8.1.1 Cambrex Company Details
  • 8.1.2 Company Description and Business Overview
  • 8.1.3 Production and Revenue of Bisacodyl
  • 8.1.4 Bisacodyl Product Introduction
  • 8.1.5 Cambrex Recent Development
• 8.2 LGM Pharma
  • 8.2.1 LGM Pharma Company Details
  • 8.2.2 Company Description and Business Overview
  • 8.2.3 Production and Revenue of Bisacodyl
  • 8.2.4 Bisacodyl Product Introduction
  • 8.2.5 LGM Pharma Recent Development
• 8.3 Kreative Organics
  • 8.3.1 Kreative Organics Company Details
  • 8.3.2 Company Description and Business Overview
  • 8.3.3 Production and Revenue of Bisacodyl
  • 8.3.4 Bisacodyl Product Introduction
  • 8.3.5 Kreative Organics Recent Development
• 8.4 Mascot Industries
  • 8.4.1 Mascot Industries Company Details
  • 8.4.2 Company Description and Business Overview
  • 8.4.3 Production and Revenue of Bisacodyl
  • 8.4.4 Bisacodyl Product Introduction
  • 8.4.5 Mascot Industries Recent Development
• 8.5 Carbosynth
  • 8.5.1 Carbosynth Company Details
  • 8.5.2 Company Description and Business Overview
  • 8.5.3 Production and Revenue of Bisacodyl
  • 8.5.4 Bisacodyl Product Introduction
  • 8.5.5 Carbosynth Recent Development
• 8.6 Pharmaffiliates Analytics & Synthetics
  • 8.6.1 Pharmaffiliates Analytics & Synthetics Company Details
  • 8.6.2 Company Description and Business Overview
  • 8.6.3 Production and Revenue of Bisacodyl
  • 8.6.4 Bisacodyl Product Introduction
  • 8.6.5 Pharmaffiliates Analytics & Synthetics Recent Development
• 8.7 Dishman
  • 8.7.1 Dishman Company Details
  • 8.7.2 Company Description and Business Overview
  • 8.7.3 Production and Revenue of Bisacodyl
  • 8.7.4 Bisacodyl Product Introduction
  • 8.7.5 Dishman Recent Development
• 8.8 Tenatra Chemie
  • 8.8.1 Tenatra Chemie Company Details
  • 8.8.2 Company Description and Business Overview
  • 8.8.3 Production and Revenue of Bisacodyl
  • 8.8.4 Bisacodyl Product Introduction
  • 8.8.5 Tenatra Chemie Recent Development
• 8.9 Nippi Incorporated JP
  • 8.9.1 Nippi Incorporated JP Company Details
  • 8.9.2 Company Description and Business Overview
  • 8.9.3 Production and Revenue of Bisacodyl
  • 8.9.4 Bisacodyl Product Introduction
  • 8.9.5 Nippi Incorporated JP Recent Development
• 8.10 Techno Drug & Intermediates
  • 8.10.1 Techno Drug & Intermediates Company Details
  • 8.10.2 Company Description and Business Overview
  • 8.10.3 Production and Revenue of Bisacodyl
  • 8.10.4 Bisacodyl Product Introduction
  • 8.10.5 Techno Drug & Intermediates Recent Development
• 8.11 Erregierre
• 8.12 Stason Pharamceuticals
• 8.13 UPI
• 8.14 U. K. Vet Chem
• 8.15 Venkatasai
• 8.16 Wuhai Yuancheng
• 8.17 Hubei Prosperity Galaxy Chemical

9 Market Forecast

• 9.1 Global Market Size Forecast
  • 9.1.1 Global Bisacodyl Capacity, Production Forecast 2019-2025
  • 9.1.2 Global Bisacodyl Production Value Forecast 2019-2025
• 9.2 Market Forecast by Regions
  • 9.2.1 Global Bisacodyl Production and Value Forecast by Regions 2019-2025
  • 9.2.2 Global Bisacodyl Consumption Forecast by Regions 2019-2025
• 9.3 United States
  • 9.3.1 Production and Value Forecast in United States
  • 9.3.2 Consumption Forecast in United States
• 9.4 European Union
  • 9.4.1 Production and Value Forecast in European Union
  • 9.4.2 Consumption Forecast in European Union
• 9.5 China
  • 9.5.1 Production and Value Forecast in China
  • 9.5.2 Consumption Forecast in China
• 9.6 Rest of World
  • 9.6.1 Japan
  • 9.6.2 Korea
  • 9.6.3 India
  • 9.6.4 Southeast Asia
• 9.7 Forecast by Type
  • 9.7.1 Global Bisacodyl Production Forecast by Type
  • 9.7.2 Global Bisacodyl Production Value Forecast by Type
• 9.8 Consumption Forecast by Application

10 Value Chain and Sales Channels Analysis

• 10.1 Value Chain Analysis
• 10.2 Sales Channels Analysis
  • 10.2.1 Bisacodyl Sales Channels
  • 10.2.2 Bisacodyl Distributors
• 10.3 Bisacodyl Customers

11 Opportunities & Challenges, Threat and Affecting Factors

• 11.1 Market Opportunities
• 11.2 Market Challenges
• 11.3 Porter's Five Forces Analysis

12 Key Findings

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details

Bisacodyl is an organic compound that is used as a stimulant laxative drug. It works directly on the colon to produce a bowel movement. It is typically prescribed for relief of constipation and for the management of Neurogenic Bowel Dysfunction, as well as part of bowel preparation before medical examinations, such as for a colonoscopy.
In 2019, the market size of Bisacodyl is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Bisacodyl.

This report studies the global market size of Bisacodyl, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Bisacodyl production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Cambrex
LGM Pharma
Kreative Organics
Mascot Industries
Carbosynth
Pharmaffiliates Analytics & Synthetics
Dishman 
Tenatra Chemie
Nippi Incorporated JP
Techno Drug & Intermediates
Erregierre
Stason Pharamceuticals
UPI
U. K. Vet Chem
Venkatasai
Wuhai Yuancheng
Hubei Prosperity Galaxy Chemical

Market Segment by Product Type
Low Purity
High Purity

Market Segment by Application
Constipation
Neurogenic Bowel Dysfunction
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Bisacodyl status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Bisacodyl manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Bisacodyl are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025